CLINICAL TRIALS PROFILE FOR REPAGLINIDE
✉ Email this page to a colleague
All Clinical Trials for repaglinide
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00072904 ↗ | Diabetes Therapy to Improve BMI and Lung Function in CF | Completed | Cystic Fibrosis Foundation | Phase 3 | 2001-06-01 | To recruit 150 adult patients with cystic fibrosis related diabetes (CFRD) without fasting hyperglycemia for a multi-center, twelve month, placebo-controlled intervention trial testing the ability of insulin or repaglinide to improve body mass index (BMI) and stabilize pulmonary function in cystic fibrosis (CF). |
NCT00072904 ↗ | Diabetes Therapy to Improve BMI and Lung Function in CF | Completed | Cystic Fibrosis Foundation Therapeutics | Phase 3 | 2001-06-01 | To recruit 150 adult patients with cystic fibrosis related diabetes (CFRD) without fasting hyperglycemia for a multi-center, twelve month, placebo-controlled intervention trial testing the ability of insulin or repaglinide to improve body mass index (BMI) and stabilize pulmonary function in cystic fibrosis (CF). |
NCT00072904 ↗ | Diabetes Therapy to Improve BMI and Lung Function in CF | Completed | Novo Nordisk A/S | Phase 3 | 2001-06-01 | To recruit 150 adult patients with cystic fibrosis related diabetes (CFRD) without fasting hyperglycemia for a multi-center, twelve month, placebo-controlled intervention trial testing the ability of insulin or repaglinide to improve body mass index (BMI) and stabilize pulmonary function in cystic fibrosis (CF). |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for repaglinide
Condition Name
Clinical Trial Locations for repaglinide
Trials by Country
Clinical Trial Progress for repaglinide
Clinical Trial Phase
Clinical Trial Sponsors for repaglinide
Sponsor Name